Sky Century Investment (SKYI) Current Deferred Revenue (2025 - 2026)

Sky Century Investment (SKYI) reported Current Deferred Revenue of $13801.0 for Q1 2026, down 42.49% quarter-over-quarter from $23998.0 in Q4 2025.

Sky Century Investment (SKYI) Current Deferred Revenue (2025 - 2026) Analysis & Trends

Sky Century Investment (SKYI) has 2 years of Current Deferred Revenue data on file, last reported at $13801.0 in Q1 2026.

Current Deferred Revenue for Q1 2026 came in at $13801.0, changed N/A year-over-year; the trailing twelve-month figure through Feb 2026 was $13801.0 (changed N/A YoY), and the FY2025 annual result was $27550.0, changed N/A from the prior year.
Current Deferred Revenue declined to $13801.0 in Q1 2026 per SKYI's latest filing, from $23998.0 in the prior quarter.
Over five years, Current Deferred Revenue peaked at $27550.0 in Q3 2025 and troughed at $1387.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn
10	Sky Century Investment	-	-	31,666.00

Download Data